NEWS & MEDIA

Tag: COVID -19

DOD Awards Contract to Siemens Healthineers to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 24, 2022 — On Jan. 21, 2022, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded a contract to Siemens Healthineers, located in Tarrytown, New York, to procure 50 million over-the-counter COVID-19 test kits. This effort supports the president’s plan to deliver 500 million free at-home COVID-19...

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 14, 2022 — Today, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Abbott Rapid Dx North America, LLC (Orlando, Florida), iHealth Lab Inc. (Mountain View, California), and Roche Diagnostics Corporation (Indianapolis, Indiana), purchasing a combined total of 380 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR)...

DOD Awards Contracts to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 10, 2022 — This weekend, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Atlantic Trading, LLC (Austin, Texas) and Medea Inc. (Pleasanton, California), purchasing a combined total of 27 million over-the-counter COVID-19 test kits. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). ...

DOD Awards $51.6 Million Contract to Goldbelt Security LLC to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 7, 2022 — On Jan. 6, 2022, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $51.6 million contract to Goldbelt Security, LLC, located in Newport News, Virginia, for delivery of over-the-counter COVID-19 test kits. This effort supports the president’s plan to deliver 500 million at-home COVID-19 tests to the nation at no cost in response to the Omicron variant. The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR). The procurement was funded through the American Rescue Plan Act to supply critical medical resources to the Nation. ...

DOD Awards Contract to Revival Health Inc. to Purchase COVID-19 Antigen Over-the-Counter Test Kits in Support of POTUS' 500 Million Free At-Home COVID-19 Tests
January 7, 2022 — On Jan. 7, 2022, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded a contract to Revival Health Inc., located in Manhattan Beach, California, to procure 13.3 million over-the-counter COVID-19 test kits. The DoD's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD's Defense Assisted Acquisition Cell (DA2), Army Contracting Command, and the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR)...

DOD Awards $136.7 Million Contract to MilliporeSigma to Establish Domestic Production Capacity of Critical Material Used in COVID-19 Point-of-Care Tests
December 30, 2021 — On Dec. 29, 2021, the Department of Defense (DOD), on behalf of and in coordination with the U.S. Department of Health and Human Services, awarded a $136.7 million contract to MilliporeSigma to establish nitrocellulose membrane production capacity in the United States. The DOD’s Defense Assisted Acquisition Cell (DA2) led this effort in coordination with the Department of the Air Force’s Acquisition COVID-19 Task Force (DAF ACT) supported by the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) who facilitates the DA2’s Screening & Diagnostics industrial base expansion efforts. This effort was funded through the American Rescue Plan Act (ARPA) to support domestic industrial base expansion for critical medical resources...

Biden Administration Secures 10 Million Courses of Pfizer’s COVID-19 Oral Antiviral Medicine as Additional Tool to Reduce Hospitalizations and Save Lives
November 18, 2021 — As part of its ongoing efforts to curb the pandemic, reduce hospitalizations, and save lives, the Biden Administration has secured 10 million treatment courses of Pfizer’s promising COVID-19 oral antiviral drug, contingent on emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA)...

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic
October 4, 2021 — The JPM CBRN Medical team is dedicated to mission, warfighter, and Nation. Their work has been instrumental in bringing novel testing capability to the U.S., delivering critical at-home technology necessary to combat the global COVID-19 pandemic. In spearheading the mission of supporting the warfighter, the team indirectly boosted the local economy and remain ready for the next threat, whether intentional or naturally-occurring...

JPM CBRN Medical Provides Relief and Recovery in the Age of a Global Pandemic
September 8, 2021 — What do global pandemic relief efforts, the U.S. Army, and a local Maryland economy have in common? The answer is fearless innovation, the right people in the right place at the right time, and an Australian-based biotech and diagnostic solutions company named Ellume. ...

DOD Awards $64.6 Million Contract to SiO2 Medical Products to Increase Domestic Production Capacity of Pharmaceutical Vials
July 29, 2021 — IMMEDIATE RELEASE - On July 26, 2021, the Department of Defense (DOD), on behalf of and in coordination with the Department of Health and Human Services (HHS), awarded a $64.6 million contract modification to SiO2 Medical Products to increase domestic production of pharmaceutical vials made of hybrid, glass-equivalent materials...

News Search

News Archive - Search by Year and Month

2026 (14)
2025 (19)
2024 (40)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

CPE CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the CPE CBRND's Capabilities Catalog, Leadership Biographies, and contracting overview documents.

CPE CBRND Public Affairs Office

The CPE CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the CPE CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the CPE CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the CPE CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.